MedTrace Logo

Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy

NCT05543057 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-09-16

No results posted yet for this study

Summary

Radiotherapy is one of the main treatments for locally advanced esophageal carcinoma (EC). The accuracy of the existing imaging methods in diagnosing and predicting therapeutic efficacy is disappointing, which increases the difficulty in clinical decision-making. In this study, based on a continuous cohort of EC treated with radiotherapy, the clinical and pathological factors of the patients are used to classify them into the appropriate therapeutic group. By multiple liquid biopsy technologies, combining with radiomics, we intend to construct prediction models of prognosis, therapeutic effect and toxicity. The aim of this RWS is to provide appropriate individualized regimen, further optimize the treatment mode based on precision radiotherapy and improve the outcome and quality of life of EC patients.

Conditions

  • Esophageal Cancer

Interventions

RADIATION

3DCRT

Three-dimensional conformal radiotherapy (3DCRT)

Sponsors & Collaborators

  • Zefen Xiao

    lead UNKNOWN

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2026-01-01
Completion
2026-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05543057 on ClinicalTrials.gov